Oxypro 5mg modified-release tablets
BNF presentation 0407020ADBSAAAK within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBSAAAK
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
12,984
NHS spend (£)
£63,724.05
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 2,320 |
| February 2025 | 47 |
| December 2024 | 589 |
| November 2024 | 2,335 |
| October 2024 | 2,509 |
| September 2024 | 8 |
| August 2024 | 185 |
| July 2024 | 2,476 |
| May 2024 | 551 |
| July 2021 | 356 |
| June 2021 | 259 |
| December 2020 | 607 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
|
Holderness Health
ODS B81025
|
77 | 02Y - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 72 | No data available |
| Unknown pharmacy | 66 | No data available |
| Unknown pharmacy | 51 | No data available |
|
Greengates Medical Group
ODS B81101
|
47 | 02Y - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 44 | No data available |
| Unknown pharmacy | 43 | No data available |
| Unknown pharmacy | 42 | No data available |
| Unknown pharmacy | 41 | No data available |
| Unknown pharmacy | 39 | No data available |